Fast Track...to What?
Executive Summary
Thierry Soursac's swift rise to the number two spot at Rhone-Poulenc Rorer indicates troubles in the big European drug firm and dissatisfaction at its parent. He's there in part to light a fire under RPR chairman and CEO Michel de Rosen.